Sign In
Buy ABT
$90.53
+2.76 (+3.14%)
At Close: Jun 23, 2026
Abbott Laboratories: An Excellent Wealth Compounder You'll Want To Own
08:15am, Thursday, 04'th Aug 2022
ABT is a diversified healthcare company with strong growth prospects, an impressive track record of shareholder returns, and a fortress balance sheet. The company is moving past its infant formula rec
Use These To Find Your Stock's Support and Resistance Levels
01:32am, Monday, 01'st Aug 2022
A stock is a trading and investing instrument representative of an underlying business but surprisingly gets too often misunderstood in a bear market.
3 Dividend Aristocrats to Buy in August
05:57am, Sunday, 31'st Jul 2022
These stocks have reliable dividends and strong underlying businesses.
7 Blue-Chip Stocks to Buy Before the Bull Market Returns
10:26am, Friday, 29'th Jul 2022
The bear market is firmly in place so long as the economy worsens. The incoming recession is a necessary headwind.
7 Large-Cap Stocks to Buy on the Dip
07:10am, Wednesday, 27'th Jul 2022
Following this year's sell-off, seasoned investors are increasingly hunting for large-cap stocks to buy on the dip. For instance, the S&P 500 index and Dow Jones Industrial Average have lost 185 and 1
Why a Product Recall Won't Change This Company's Prospects
06:15am, Wednesday, 27'th Jul 2022
This company's business won't fail that easily.
Is Abbott Laboratories stock a ‘buy' after market-beating Q2 results?
09:04pm, Thursday, 21'st Jul 2022
Abbott Laboratories (NYSE: ABT) down more than 20% for the year is an opportunity to buy a quality name at a deep discount, says Brenda Vingiello. She's the Chief Investment Officer at Sand Hill Globa
Final Trades: Boeing, Invitation Homes, Abbott Labs & more
02:27pm, Thursday, 21'st Jul 2022
The "Halftime Report" traders give their top picks to watch for the second half.
Abbott is now aiming to recover the baby-formula market share that it lost
03:46pm, Wednesday, 20'th Jul 2022
Abbott Laboratories ABT, -1.35% is focused on recovering its position in the baby-formula market in the U.S. following the recall that required the intervention of the Biden administration to ensure t
A Debt-Free and Fairly Valued Medical Devices Company
02:42pm, Wednesday, 20'th Jul 2022
LeMaitre Vascular Inc. ( LMAT , Financial) has been on a roll—it has generated robust financial results and metrics that produced a high GF Score. But the share price has been in a slump.
Abbott earnings top estimates as baby formula losses offset by COVID test sales
01:33pm, Wednesday, 20'th Jul 2022
Yahoo Finance medical reporter Anjalee Khemlani breaks down second-quarter earnings for Abbott Laboratories.
Abbot Laboratories Stock Lower on Disappointing Forecast
10:34am, Wednesday, 20'th Jul 2022
Abbott Laboratories (NYSE:ABT) is down 1.7% to trade at $107.79 at last glance, despite the company's strong second-quarter earnings and revenue, both of which beat estimates.
Abbott Laboratories (ABT) CEO Robert Ford on Q2 2022 Results - Earnings Call Transcript
10:21am, Wednesday, 20'th Jul 2022
Abbott Laboratories (NYSE:ABT ) Q2 2022 Earnings Conference Call July 20, 2022 9:00 AM ET Company Participants Scott Leinenweber - Vice President, Investor Relations, Licensing & Acquisition Robert Fo
Abbott (ABT) Q2 Earnings and Revenues Top Estimates
10:08am, Wednesday, 20'th Jul 2022
Abbott (ABT) delivered earnings and revenue surprises of 31.19% and 8.67%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Abbott Lifts Annual Profit Guidance On Higher COVID-19 Test Sales
10:00am, Wednesday, 20'th Jul 2022
Abbott Laboratories (NYSE: ABT) has reported Q2 FY22 adjusted EPS of $1.43, up 22.2% Y/Y, better than the consensus of $1.12. Q2 sales of $11.3 billion increased 10.1% on a reported basis and 14.3%
